Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Evaluation of Efficacy, Safety and Immunogenicity of GX-19N in Healthy Individuals Who Have Received COVID-19 Vaccines

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT05067946
Recruitment Status : Not yet recruiting
First Posted : October 5, 2021
Last Update Posted : October 5, 2021
PT Kalbe Farma TBK
Information provided by (Responsible Party):
Genexine, Inc.

No Study Results Posted on for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : October 2022
Estimated Study Completion Date : October 2023